Uscom Ltd

Uscom Ltd

UCM · AU · Healthcare / Medical Devices

0.012AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.012
Open0.012
Day Range0.012 – 0.012
52-Week Range0.012 – 0.012
Volume0
Market Cap3.12M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta-1.34
50-Day Avg0.012
200-Day Avg0.012

About

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that uses multi-path ultrasound; SpiroSonic FLO and SpiroSonic AIR, a digital multi-path ultrasonic spirometer for pulmonary function diagnostic and monitoring COPD and asthma; and SpiroSonic SMART for use by general practitioners and patients for screening COPD and asthma. It serves hospitals and medical care locations through its distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med)
  • Employees0
  • Headquarters66 Clarence Street, Sydney, NSW, Australia, 2000, Australia
  • Websitehttps://www.uscom.com.au

Leadership

  • Dr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med)Founder, Executive Chairman, CEO & Chief Scientist · b. 1953
  • Mr. Brett Thomas Crowley B.Com., C.A., DipLawCompany Secretary & Independent Non-Executive Director · b. 1957
  • Mr. Nicholas Schicht BEngGeneral Manager · b. 1966

Financials

Income Statement

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue190.00K384.39K480.11K1.12M871.26K1.05M1.63M836.91K838.00K794.13K578.75K1.06M2.04M2.94M3.50M2.86M3.64M3.48M3.86M2.51M2.66M3.73M2.58M
Growth (%)-+102.31%+24.90%+133.20%-22.18%+20.71%+55.02%-48.67%+0.13%-5.23%-27.12%+82.55%+93.04%+43.99%+19.15%-18.21%+27.27%-4.45%+10.87%-34.95%+6.16%+39.89%-30.80%
Cost of Revenue54.00K57.13K111.34K201.29K125.04K149.20K426.09K207.99K251.54K212.92K140.64K235.31K341.72K708.01K711.20K605.35K687.25K3.02M3.08M3.72M3.69M611.15K348.66K
Gross Profit-327.26K368.76K918.33K746.23K902.51K1.20M628.92K586.45K581.21K438.11K821.19K1.70M2.23M2.79M2.26M2.95M458.00K781.70K-1.21M-1.03M3.12M2.23M
Gross Margin-85.14%76.81%82.02%85.65%85.81%73.87%75.15%69.98%73.19%75.70%77.73%83.24%75.89%79.67%78.85%81.13%13.16%20.26%-48.21%-38.50%83.60%86.48%
Operating Expense-1.22M3.97M5.16M5.11M3.46M3.13M2.80M3.50M2.80M2.23M2.46M2.85M4.13M4.58M4.21M4.33M2.26M2.21M1.40M1.89M5.49M5.96M
Operating Income--894.57K-3.60M-4.24M-4.37M-2.56M-1.93M-2.17M-2.91M-2.21M-1.79M-1.64M-1.16M-1.90M-1.79M-1.95M-1.38M-1.80M-1.43M-2.61M-2.92M-2.38M-3.73M
Operating Margin--232.72%-749.93%-378.74%-501.11%-243.21%-118.28%-258.89%-347.43%-278.79%-309.06%-155.09%-56.68%-64.82%-51.17%-68.19%-37.88%-51.67%-37.14%-103.80%-109.47%-63.75%-144.62%
EBITDA--2.24M-3.05M-4.10M-4.17M-2.42M-1.81M-2.06M-2.81M-2.11M-1.71M-1.62M-1.41M-2.05M-1.51M-1.65M-1.04M-1.12M-833.84K-1.84M-2.50M-1.51M-3.06M
EBITDA Margin--582.50%-635.54%-366.26%-479.11%-229.65%-111.24%-246.32%-335.09%-265.76%-295.41%-153.67%-69.16%-69.96%-43.03%-57.56%-28.69%-32.27%-21.61%-73.35%-93.84%-40.50%-118.50%
Net Income--1.25M-2.55M-3.37M-3.20M-2.17M-1.10M-1.76M-2.69M-1.82M-1.37M-1.52M-1.22M-1.92M-1.80M-1.96M-1.39M-1.33M-924.24K-1.97M-2.59M-2.07M-3.30M
Net Income Margin--325.63%-530.28%-301.37%-366.92%-206.76%-67.46%-210.02%-320.52%-229.75%-237.01%-143.92%-59.61%-65.21%-51.47%-68.52%-38.15%-38.26%-23.96%-78.59%-97.25%-55.67%-128.07%
R&D560.00K342.05K527.90K540.97K519.88K473.74K572.10K531.42K502.04K509.86K531.39K396.52K488.18K542.90K614.12K845.44K759.57K810.00K815.86K43.30K48.59K21.94K32.07K
R&D as % of Total Revenue294.74%88.99%109.95%48.32%59.67%45.04%35.09%63.50%59.91%64.20%91.82%37.53%23.94%18.49%17.55%29.54%20.86%23.28%21.15%1.73%1.82%0.59%1.24%
Interest Expense01.80K2.11K000000000009.09K4.91K1.46K89.90K95.51K78.72K102.92K131.53K133.93K
Interest Expense % of Total Revenue0.00%0.47%0.44%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.26%0.17%0.04%2.58%2.48%3.14%3.86%3.53%5.19%

Balance Sheet

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets15.52M14.60M12.12M9.15M5.93M3.76M3.53M2.83M3.52M1.83M2.82M3.77M2.94M5.71M4.49M5.38M4.14M5.92M5.33M7.99M5.18M5.13M3.25M
Total Liabilities75.06K311.69K372.46K641.30K438.38K354.31K469.31K381.38K388.69K358.29K460.52K449.82K647.69K773.75K708.23K530.76K650.99K2.50M2.26M2.06M2.14M2.07M3.29M
Total Equity15.44M14.29M11.75M8.51M5.50M3.41M3.06M2.45M3.14M1.47M2.35M3.32M2.29M4.94M3.78M4.84M3.49M3.42M3.08M5.94M3.04M3.06M-38.22K
Cash14.89M13.32M10.55M7.22M4.36M2.51M1.91M1.38M2.13M544.46K541.20K1.58M526.32K2.84M1.66M2.49M1.21M1.91M1.70M1.69M1.88M2.52M966.66K
Total Debt4.71K12.94K19.41K6.47K13.05K4.35K-----------1.62M1.43M1.31M1.09M989.28K2.26M
Net Debt-14.88M-13.31M-10.53M-7.22M-4.35M-2.50M-1.91M-1.38M-2.13M-544.46K-541.20K-1.58M-526.32K-2.84M-1.66M-2.49M-1.21M-288.21K-265.40K-376.91K-787.15K-1.53M1.30M

Cash Flow

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow---2.59M-3.19M-3.27M-1.67M-1.02M-1.50M-2.19M-1.66M-971.58K-1.24M-992.80K-1.29M-952.04K-1.70M-1.22M-283.23K54.98K-967.51K-1.42M-1.16M-2.71M
Investing Cash Flow---191.35K-135.11K403.93K-177.16K-162.79K-156.90K-88.02K-74.51K-92.93K-90.63K-76.98K-685.20K-247.55K-338.75K-111.83K-38.16K-33.35K-115.31K-151.94K-57.55K-68.78K
Financing Cash Flow1.55M14.60M----579.10K1.12M3.03M150.00K1.06M2.37M13.26K4.29M23.38K2.86M46.23K1.03M-281.87K4.05M-952.96K1.57M1.21M
Capital Expenditure107.00K85.00K191.35K145.11K150.73K177.16K162.79K156.90K88.02K74.51K92.93K90.63K16.61K2.51K57.55K171.84K68.53K38.16K33.35K115.31K151.94K57.55K14.25K
Free Cash Flow---2.78M-3.33M-3.42M-1.85M-1.18M-1.65M-2.28M-1.73M-1.06M-1.33M-1.01M-1.29M-1.01M-1.87M-1.29M-321.38K21.63K-1.08M-1.58M-1.22M-2.72M
Dividends Paid-------------00--253.23K292.74K3.99M619.68K--
FCF to OCF--107.39%104.55%104.61%110.60%116.02%110.47%104.01%104.50%109.56%107.33%101.67%100.19%106.05%110.13%105.62%113.47%39.34%111.92%110.67%104.95%100.53%
Dividend Paid to FCF-------------0.00%0.00%---78.79%1353.58%-368.85%-39.32%--

Earnings

Report DateFeb 23, 2016Aug 17, 2016Feb 13, 2017Aug 21, 2017Feb 14, 2018Aug 21, 2018Feb 27, 2019Aug 19, 2019Mar 1, 2020Aug 17, 2020Feb 23, 2021Aug 18, 2021Feb 23, 2022Aug 17, 2022Feb 23, 2023Feb 26, 2025Sep 3, 2025
EPS Estimate0.000.000.000.00-0.000.000.000.000.000.000.000.00--0.00-
EPS Actual-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.010.000.000.00-0.01-0.01-0.01-0.01-0.01
Surprise-----------------
Timing------------After-hoursAfter-hoursAfter-hours-After-hours

Key Statistics & Ratios

Market Cap3.12M
Enterprise Value4.42M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.29
Price / Book2.16
EPS-0.02
Book Value0.001
Revenue (TTM)2.41M
Gross Profit (TTM)2.06M
EBITDA-2.87M
Profit Margin-53.60%
Operating Margin-105.76%
Return on Equity-110.01%
Return on Assets-72.36%
Shares Outstanding260.15M
Shares Float58.44M
Beta-1.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%